Is a Form 483 the same as a Warning Letter?

No. A Form 483 lists an FDA investigator’s observations at the close of an inspection; it is not a final agency determination. FDA may or may not follow up with a Warning Letter depending on the firm’s response and the severity of the findings.

Where can I read the full Form 483?

The verbatim inspection record is the source of truth — always confirm citation language against the original FDA document before acting.

What is an FDA Form 483?

A Form FDA 483 lists an FDA investigator’s written observations at the close of a facility inspection, issued under section 704(b) of the Federal Food, Drug, and Cosmetic Act. It documents conditions the investigator judged may violate FDA regulations. A 483 is not an enforcement action or a final determination that a violation occurred.

Does this Form 483 mean Veterinary Pharmacy Corporation violated the law?

No. A Form 483 documents an investigator's observations only. FDA reviews the firm's written response and any corrective actions taken before deciding whether further action is warranted, and many 483s are closed without additional enforcement once a firm shows adequate correction.

Form 483 Record: Veterinary Pharmacy Corporation, March 19, 2026

At a glance: FDA inspected Veterinary Pharmacy Corporation in Minnesota and issued a Form 483 listing 3 inspectional observations following an inspection that concluded 2026-03-19. FDA records classify Veterinary Pharmacy Corporation as a compounding pharmacy. A Form 483 documents an investigator's findings at the close of an inspection under the Federal Food, Drug, and Cosmetic Act; it is not a final agency compliance determination. The observations on this page are drawn directly from the FDA-issued Form 483 record. A Form FDA 483 is issued at the close of an FDA facility inspection to list conditions an investigator observed that may violate the Federal Food, Drug, and Cosmetic Act or its implementing regulations. It reflects the investigator's professional judgment at that point in time and is not a final agency determination, an enforcement action, or proof that a violation occurred. Firms are expected to respond in writing, typically within 15 business days, describing the corrective and preventive actions they plan to take. FDA reviews that response, along with any follow-up evidence, before deciding what happens next. Many 483s are resolved through corrective action alone. When FDA judges a firm's response inadequate, or when the underlying conditions are serious enough, the observations documented here can lead to a Warning Letter or further regulatory action. This page presents the observations exactly as recorded on the FDA-issued document; always confirm citation language against the original record before relying on it.

Key facts

Firm	Veterinary Pharmacy Corporation
FEI / inspection ID	3002726048
Inspection end date	March 19, 2026
Citation count	3

Citations explained

Observation 1 — Contamination was observed in your production area and areas adjacent to production

Contamination was observed in your production area and areas adjacent to production areas. Specifically, A) A pallet of used compounding equipment was observed in the non-classified Amoxicillin storage room. Items on this pallet included, but were not limited to, used proces (b) (4)which were coated with yellow residue, metal fittings, and hoses. All equipment on this pallet appeared to be coated with a layer of white powder. Your staff stated that this pallet ofused equipment had been present in this location for approximately 1.5 to 2 years. This pallet is located immediately adjacent to the door leading to Amoxicillin Room :mmII where finished product compounding and packaging of Amoxicillin products takes place. B) Widespread and extensive damage was observed on the painted drywall walls in the Amoxicillin processing area. This damage included an approximately 6-inch long and 3-inch deep hole punched in a wall from the handle of an over-extended door, multiple scrapes in paint and drywall ranging from 1 to 6 inches, and broken floor ceramic molding. This damage was noted approximately 10 feet from the chute where Amoxicillin capsules werej(b} (4) 1openly into th) (4fcontainer ~

Observation 2 — Failure to conduct media fills that closely simulate aseptic production operations under

Failure to conduct media fills that closely simulate aseptic production operations under the worst-case, most-challenging, and stressful conditions. Specifically, Aseptic process simulations (media fills), along with the governing procedure SOP CR-02 - Aseptic Technique & Gloved Fingertip I Thumb Test- are deficient in that they do not simulate the finished product container size, number of units, or worst-case conditions that may arise during compounding activities. Media fills conducted by yoUL.fii],11J1L_( ) t:o) simulate aseotic. processes utilize(b) (4) which contain a total of :C b) (1} , JV bags and associated equipment. 1 b 4 1is used by each sterile compounding technician as part pf theirK6H4J :::J aseptic process simulation evaluation. During a review of your sterile compounding records for March 4 2026, a Jot size o ~b) < ~ 2000 ml bags of Iron 20% (200 mg/ml) was noted in the compounding of Lot #V20030526 on 05MAR2026. This batch was compounded to fulfill Rx i H 6 J.(bJ<7XCland shipped to your customer on 3/11/2026. Additional batch sizes o (b) (4 , an ~ 2000 mL bags were also noted in compounding records from 04MAR2026 - 10MAR2026. Additionally, Form CR-37 - Periodic C

Observation 3 — Deviation from the procedural requirements of a decree of injunction. Specifically,

Deviation from the procedural requirements of a decree of injunction. Specifically, EMPI.OYEE(S) SIGNATURE DATE ISSUED SEE REVERSE Ni cho l as J Presto , Inves tig a to r 3/19/2026 OF THIS PAGE Beatrix D Hi ppe , Inves tig a to r MNU JPr•io Va ish a li Patel , Inves tig a to r i~MCHCI.AS J . J X ~~al. QG.1 Wl:ll$ PAGE2of4 PAGES FORM FDA 433 (09/ 08) PREMOUS EDmONOBSOLErrE INSPECTION AL OB SERVATIONS -- 2 of 5 -- DEPARTMENT OF HEALTH AND HUMAN SERVICES FOOD AND DRUG ADMINISTRATJON DISTRICT ADDRESS AND PHONE NUMBER DATE(S)OF INSPECTI ON 250 Marque tt e Av e, St e. 600 3/9/2026 - 3/ 1 9/2026* Mi nneapo li s, MN 5540 1 FEI NUMBER 3002726048(6 12) 334 - 4100 Fax: (6 12) 334 - 4134 NAME ANO TI RE OF INDI VIDUAL TO WHOM REPORT ISSUED Ms. Anne M Reese, Phar mac i s t I n Charge FIRM NAME STREET ADDRESS Ve t er i nary Phar macy Corpora ti on 2008 Su nr i se Dr CITY, STATE, ZIP CODE.COUNTRY TYPE ESTAII. ISHMENT INSPECTED Sa i nt Pe t er , MN 56082 - 5384 Ve t er i nary Compo u nd i ng Pharmacy Consent decree number OO-CV-2725 Paragraph 17 requires you to establish, continuously maintain and/or follow procedures, processes and controls to ensure the following: Paragraph 17(A)(vi), Establish a

What a Form 483 means

A Form FDA 483 is issued at the close of an FDA facility inspection to list conditions an investigator observed that may violate the Federal Food, Drug, and Cosmetic Act or its implementing regulations. It reflects the investigator's professional judgment at that point in time and is not a final agency determination, an enforcement action, or proof that a violation occurred. Firms are expected to respond in writing, typically within 15 business days, describing the corrective and preventive actions they plan to take. FDA reviews that response, along with any follow-up evidence, before deciding what happens next. Many 483s are resolved through corrective action alone. When FDA judges a firm's response inadequate, or when the underlying conditions are serious enough, the observations documented here can lead to a Warning Letter or further regulatory action. This page presents the observations exactly as recorded on the FDA-issued document; always confirm citation language against the original record before relying on it.

Veterinary Pharmacy Corporation’s FDA history

Argus HQ has recorded 1 total FDA action tied to Veterinary Pharmacy Corporation: 0 warning letters, 0 recalls, 0 approval records, and 1 Form 483 inspection citation.

Frequently asked questions

Is a Form 483 the same as a Warning Letter?: No. A Form 483 lists an FDA investigator’s observations at the close of an inspection; it is not a final agency determination. FDA may or may not follow up with a Warning Letter depending on the firm’s response and the severity of the findings.
Where can I read the full Form 483?: The verbatim inspection record is the source of truth — always confirm citation language against the original FDA document before acting.
What is an FDA Form 483?: A Form FDA 483 lists an FDA investigator’s written observations at the close of a facility inspection, issued under section 704(b) of the Federal Food, Drug, and Cosmetic Act. It documents conditions the investigator judged may violate FDA regulations. A 483 is not an enforcement action or a final determination that a violation occurred.
Does this Form 483 mean Veterinary Pharmacy Corporation violated the law?: No. A Form 483 documents an investigator's observations only. FDA reviews the firm's written response and any corrective actions taken before deciding whether further action is warranted, and many 483s are closed without additional enforcement once a firm shows adequate correction.

See if this 483 escalates to a warning letter — before your auditor asks.

Free weekly briefing tracks every FDA inspection outcome.

Full FDA history for Veterinary Pharmacy Corporation

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2026). Form 483 Record: Veterinary Pharmacy Corporation, March 19, 2026 — 3 Citations. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/483/veterinary-pharmacy-corporation-3002726048-2026-03-19

MLA

"Form 483 Record: Veterinary Pharmacy Corporation, March 19, 2026 — 3 Citations." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/483/veterinary-pharmacy-corporation-3002726048-2026-03-19.

Chicago

Argus HQ Research. "Form 483 Record: Veterinary Pharmacy Corporation, March 19, 2026 — 3 Citations." Digital Empire Holdings LLC. Accessed August 17, 2026. https://argushq.ai/483/veterinary-pharmacy-corporation-3002726048-2026-03-19.

BibTeX

@misc{argushq_argushq_ai_483_veterinary_pharmacy_corporation_3002726048_2026_03_19_2026,
  title = {Form 483 Record: Veterinary Pharmacy Corporation, March 19, 2026 — 3 Citations},
  author = {{Argus HQ Research}},
  year = {2026},
  publisher = {Digital Empire Holdings LLC},
  url = {https://argushq.ai/483/veterinary-pharmacy-corporation-3002726048-2026-03-19},
  note = {Accessed: August 17, 2026}
}

Source: FDA.gov — Inspection Classification Database ↗